• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Curaleaf to Acquire Nevada-Based Acres Cannabis for $70 Million

Share:

March 25, 2019

Massachusetts-based cannabis company Curaleaf announced Monday it purchased Acres Cannabis, which according to the company has the largest cultivation facilities in Nevada, for $70 million in cash and stock.

Curaleaf will pay $25 million in cash, and $45 million in Curaleaf stock.

Curaleaf will add Acres 269,000 square feet of operating cultivation facilities with further plans to add on the company’s 37 acres of land in Amargosa Valley, Nevada.

“The acquisition of Acres is a major step in expanding our vertical platform in Nevada. Acres operates a flagship dispensary in the heart of Las Vegas, complementing our existing assets in the state extremely well, and importantly, we can control the consistency, quality and production cost of our own cannabis products,” said Joseph Lusardi, CEO of Curaleaf. “We have built the most accessible, trusted and reliable cannabis brand and are extremely excited about the prospects in Nevada both for retail and wholesale activity.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

The addition of Acres’ cultivation platform will provide Curaleaf with 42,000 square feet of functioning climate-controlled greenhouses and 227,000 square feet of outdoor cultivation.

“Curaleaf’s management, vision and rapid expansion plans made them the natural fit for Acres.” Acres CEO John Mueller said. “Acres believes Curaleaf is very well positioned to continue to be the largest cannabis operator in the U.S. giving our partners significant upside.”

Will You Have Enough Money Retire?

Want to learn about retirement planning from some of the nation’s top experts? Join TheStreet’s Robert “Mr. Retirement” Powell live in New York on April 6 for our Retirement Strategies Symposium. For a limited time, tickets are available for $99 for this full-day event.

Date: March 25, 2019

Source: TheStreet

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Aktana Lands $20M For AI-Enabled Decision Support For Life SciencesAktana Lands $20M For AI-Enabled Decision Support For Life Sciences
  • Alterra.ai and MyMO Launch a Chatbot That can Answer Questions on the Coronavirus OutbreakAlterra.ai and MyMO Launch a Chatbot That can Answer Questions on the Coronavirus Outbreak
  • Indonesia’s Halodoc Raises Close to a Total of $100M After Latest Funding RoundIndonesia’s Halodoc Raises Close to a Total of $100M After Latest Funding Round
  • Marijuana Company of America Acquires Interest in Licensed California Manufacturing & Distribution CompanyMarijuana Company of America Acquires Interest in Licensed California Manufacturing & Distribution Company
  • Science 37® and Xperiome™ Partner to Increase the Efficiency and Speed of Rare Disease Studies for Patients and ProvidersScience 37® and Xperiome™ Partner to Increase the Efficiency and Speed of Rare Disease Studies for Patients and Providers
  • A Patient Engagement Strategy Needs to Deliver a Holistic ExperienceA Patient Engagement Strategy Needs to Deliver a Holistic Experience
  • Conatus Pharmaceuticals and Histogen Enter into Definitive Merger AgreementConatus Pharmaceuticals and Histogen Enter into Definitive Merger Agreement
  • Aurobindo Acquires Apotex Inc’s Business in 5 European Countries for €74 MillionAurobindo Acquires Apotex Inc’s Business in 5 European Countries for €74 Million

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications